Jamie Hartford 1

July 29, 2016

1 Min Read
EndoStim Inc.

EndoStim Inc., based in St. Louis, MO, and The Hague, The Netherlands, has developed a laparoscopically implanted stimulation system that delivers electrical impulses to treat gastroesophageal reflux disease. In May, the company secured $25 million in venture funding that will help it conduct a pivotal U.S. clinical trial.

Continue >>

[image courtesy of the company]

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like